Since LINC01537 acts as a tumor suppressor gene via interaction with PDE2A to depress tumor energy metabolism, it will be of substantial interest to use this lncRNA accompanied with other biomarkers as a tool for assessing lung cancer survival and devise drugs to target it. This evidence concerns the gene PDE2A and lung carcinoma.